Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EBOS Group Limited ( (AU:EBO) ) has provided an announcement.
EBOS Group Limited has announced a change in its substantial holding in MedAdvisor Limited, with its voting power being diluted from 9.81% to 8.65% due to the issuance of new shares by MedAdvisor. This change in voting power may impact EBOS’s influence in MedAdvisor, potentially affecting its strategic decisions and stakeholder interests.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$39.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services including wholesale distribution of pharmaceuticals, medical devices, and related healthcare products. The company focuses on serving healthcare providers and consumers across various markets.
Average Trading Volume: 63,652
Technical Sentiment Signal: Buy
Current Market Cap: A$7.26B
Find detailed analytics on EBO stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue